Home / Stocks / ELV

ELV insider trading

Elevance Health, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$5.1M
Buys · last 90 days
2 · $1.4M
Most recent buy
2026-07-17

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-17BOUDREAUX GAIL
President and CEO
Bought2,725$367.79$1.0M
2026-07-17PERU RAMIRO G
Director
Bought1,000$366.05$366k
2026-03-06COLLIS STEVEN H
Director
Bought3,000$289.84$870k
2025-08-21DeVore Susan D.
Director
Bought1,200$312.15$375k
2025-07-18BOUDREAUX GAIL
President and CEO
Bought8,500$286.94$2.4M
2025-04-25Kaye Mark
EVP & CFO
Sold4,588$424.82$1.9M
2025-03-05Kendrick Charles Morgan JR
EVP & President, Commercial
Sold3,504$396.30$1.4M
2024-10-18Kendrick Charles Morgan JR
EVP & President, Commercial
Sold7,417$432.14$3.2M

Most active insider buyers

InsiderRoleBuysTotal bought
BOUDREAUX GAILPresident and CEO2$3.4M
COLLIS STEVEN HDirector1$870k
DeVore Susan D.Director1$375k
PERU RAMIRO GDirector1$366k

See ELV on the chart

Every insider buy and sell for ELV plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.